Meta-inflammation in obesity disrupts insulin signaling through alterations in adipokine secretion and excessive free fatty acid (FFA) release, forming a pro-inflammatory microenvironment that impairs insulin sensitivity and reduces glucose uptake in peripheral tissues (43). The gene discussed is INS; the disease is obesity disorder.